Richard G Ellenbogen, | |
Harborview Medical Center, Pbs Building 401 Broadway, Seattle, WA 98122 | |
(206) 744-9300 | |
Not Available |
Full Name | Richard G Ellenbogen |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 41 Years |
Location | Harborview Medical Center, Seattle, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679659478 | NPI | - | NPPES |
8212821 | Medicaid | WA | |
227960 | Other | INTERNAL ID-MOTOR VEHICLE ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD00035342 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Harborview Medical Center | Seattle, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their physical activity and ability to accomplish the basic pursuits of daily life, researchers from The University of Texas MD Anderson Cancer Center reported today in Cancer.
Today, Burnham Institute for Medical Research (Burnham) officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando's Medical City as a life science center. Burnham at Lake Nona is the research anchor for the new development in southeast Orange County and the east coast campus of the La Jolla, Calif.-based institute.
Many women do not fully appreciate the consequences of delaying motherhood, and expect that assisted reproductive technologies can reverse their aged ovarian function, Yale researchers reported in a study published in a recent issue of Fertility and Sterility.
Seizures that occur in the first few weeks of life are a major predictor of future adverse neurological outcomes. Currently approved antiepileptic drugs (AEDs) are effective in stopping seizures in less than 50% of these neonatal cases. The approved therapies can also have undesirable side effects.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
› Verified 9 days ago
Entity Name | The Association Of University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their physical activity and ability to accomplish the basic pursuits of daily life, researchers from The University of Texas MD Anderson Cancer Center reported today in Cancer.
Today, Burnham Institute for Medical Research (Burnham) officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando's Medical City as a life science center. Burnham at Lake Nona is the research anchor for the new development in southeast Orange County and the east coast campus of the La Jolla, Calif.-based institute.
Many women do not fully appreciate the consequences of delaying motherhood, and expect that assisted reproductive technologies can reverse their aged ovarian function, Yale researchers reported in a study published in a recent issue of Fertility and Sterility.
Seizures that occur in the first few weeks of life are a major predictor of future adverse neurological outcomes. Currently approved antiepileptic drugs (AEDs) are effective in stopping seizures in less than 50% of these neonatal cases. The approved therapies can also have undesirable side effects.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
› Verified 9 days ago
Entity Name | The Association Of Chrmc And University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255449963 PECOS PAC ID: 9133032964 Enrollment ID: O20031107000585 |
News Archive
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their physical activity and ability to accomplish the basic pursuits of daily life, researchers from The University of Texas MD Anderson Cancer Center reported today in Cancer.
Today, Burnham Institute for Medical Research (Burnham) officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando's Medical City as a life science center. Burnham at Lake Nona is the research anchor for the new development in southeast Orange County and the east coast campus of the La Jolla, Calif.-based institute.
Many women do not fully appreciate the consequences of delaying motherhood, and expect that assisted reproductive technologies can reverse their aged ovarian function, Yale researchers reported in a study published in a recent issue of Fertility and Sterility.
Seizures that occur in the first few weeks of life are a major predictor of future adverse neurological outcomes. Currently approved antiepileptic drugs (AEDs) are effective in stopping seizures in less than 50% of these neonatal cases. The approved therapies can also have undesirable side effects.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Richard G Ellenbogen, Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Richard G Ellenbogen, Harborview Medical Center, Pbs Building 401 Broadway, Seattle, WA 98122 Ph: (206) 744-9300 |
News Archive
Breast cancer survivors who participated in Active Living After Cancer, an evidence-based 12-week group program, markedly increased their physical activity and ability to accomplish the basic pursuits of daily life, researchers from The University of Texas MD Anderson Cancer Center reported today in Cancer.
Today, Burnham Institute for Medical Research (Burnham) officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando's Medical City as a life science center. Burnham at Lake Nona is the research anchor for the new development in southeast Orange County and the east coast campus of the La Jolla, Calif.-based institute.
Many women do not fully appreciate the consequences of delaying motherhood, and expect that assisted reproductive technologies can reverse their aged ovarian function, Yale researchers reported in a study published in a recent issue of Fertility and Sterility.
Seizures that occur in the first few weeks of life are a major predictor of future adverse neurological outcomes. Currently approved antiepileptic drugs (AEDs) are effective in stopping seizures in less than 50% of these neonatal cases. The approved therapies can also have undesirable side effects.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
› Verified 9 days ago
George A Ojemann, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-5637 | |
Mr. Trent Lane Tredway, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 Olive Way Apt 2502, Seattle, WA 98101 Phone: 206-623-1334 Fax: 206-623-1677 | |
Daniel A Lazar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1560 N 115th St, 209, Seattle, WA 98133 Phone: 206-368-1701 Fax: 206-363-0019 | |
Mohammed Basamh, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 550 17th Ave Ste 500, Seattle, WA 98122 Phone: 206-320-2451 | |
Dr. Christoph Paul Hofstetter, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Campus Box 356470, Room Rr734, Seattle, WA 98195 Phone: 507-202-9523 | |
David Keisho Su, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Lenora St, 501, Seattle, WA 98121 Phone: 559-260-0047 | |
Syed Shabaz Azeem, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |